Professor Alan Boyd is an internationally recognised scientist, educator and entrepreneur whose pioneering work in cell and gene therapies led to the worlds first approved gene therapy for an inherited retinal disease. He has contributed directly to the licensing of more than 25 medicines, transforming outcomes for patients with rare and serious conditions.A founding member of FPM, Professor Boyd played a pivotal role in establishing pharmaceutical medicine as a recognised specialty in the UK, and served as President of FPM from 2015 to 2018. His outstanding services to life sciences innovation and pharmaceutical medicine education were recognised with an MBE in the 2026 New Year Honours.